Company profilePharmaceutical#48 of 1,318 in Pakistan1 DRAP alert

PLATINUM PHARMACEUTICALS (PVT.) LTD.

Pharmaceutical company · 246 brands · 221 molecules

Ranked #34 of 178 companies in Antiinflammatory And Antirheumatic Products

246 registered products 57 pharmaceutical brands 221 distinct molecules 1 DRAP alert

Company overview

246
registered products
57
pharmaceutical brands
221
distinct molecules
12
therapeutic classes
1
DRAP alerts

PLATINUM PHARMACEUTICALS (PVT.) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 246 product registrations across 221 distinct molecules. It is the 48th largest registrant in Pakistan by product count, and ranks 34th of 178 in Antiinflammatory And Antirheumatic Products. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Throat Preparations. DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PLATINUM

222 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

127
ceilings with an approval date
31
not revised in 2+ years
2024
oldest approval year
202431
202696
Longest without revision

Top molecules by brand count

Therapeutic classes

Antiinflammatory And Antirheumatic Products · 6Throat Preparations · 6Stomatologicals Preparations · 5Antiepileptics · 5Drugs For Obstructive Airway Diseases, Systemic · 5Anti-Infectives · 5Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 4Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 4Neuro · 4Quinolone Antibacterials · 4Other Beta-Lactam, Cephalosporins & Penems · 3Antihistamines For Systemic Use · 3

Conditions treated

General Infections · 4Pain Killers · 3Migraine/Vertigo · 1Epilepsy/Convulsion · 1Ulcer/Reflux/Flatulence/Acidity · 1Anxiety/Depression/Insomnia · 1Hormonal Therapy · 1Hypertension · 1Asthma/Copd · 1Schizophrenia/Psychosis · 1Fungal Infection · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official194 products · Rs 33.19 – Rs 12,796.42
DVAGO58 products · Rs 79.1 – Rs 1,198
Servaid23 products · Rs 87.5 – Rs 1,155
Median across source: Rs 255

Regulatory record

1 alert in the DRAP feed we track.

Combating Substandard and Falsified Products : Public Alert Reporting
2024-04-04

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 145 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
GENOME PHARMACEUTICALS (PVT) LTD holds 74 molecules not in this portfolio
AcitretinAnastrazoleAnastrozoleAprepitantArtesunateBupropion
SEARLE PAKISTAN (PVT.) LTD. holds 191 molecules not in this portfolio
AcetazolamideAdalimumabAlprazolamAmilorideAminophyllineAmitriptyline

Get the full profile for PLATINUM

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.